Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis

97469

CENTERS FOR DISEASE CONTROL AND PREVENTION → HEALTH AND HUMAN SERVICES, DEPARTMENT OF.CENTERS FOR DISEASE CONTROL AND PREVENTION.CDC OFFICE OF ACQUISITION SERVICES → CDC OFFICE OF ACQUISITION SERVICES

AI Summary

CDC seeks a contractor to perform market forecast analyses for a West Nile virus (WNV) vaccine and an anti-WNV monoclonal antibody for prophylaxis. The procurement is a combined synopsis/solicitation issued by the CDC Office of Acquisition Services, with offers due August 26, 2026, in Atlanta, GA. Firms with expertise in biopharmaceutical market analysis and forecast modeling for vaccines or biologics should bid.

Key Requirements

• •Expertise in market forecasting for vaccines and monoclonal antibodies, likely including biopharmaceutical market analysis, regulatory pathway understanding, and quantitative modeling. NAICS 541715 indicates R&D services in life sciences, so technical and scientific qualifications are critical.

Details

Point of Contact

Iris Gonzalez

qsx8@cdc.gov

Classification Code

AN11